Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.
According to the primary researcher, a single treatment of a breakthrough gene-editing therapy has altered the life of a group of patients suffering from a hereditary illness.
A new study suggests that a treatment using the CRISPR genome editing technology alleviates swelling and reduces the frequency of attacks in hereditary angioedema patients.